Please note this website is still in development
ISRCTN No: ISCRTN51267295
IRAS No: 298723
NIHR funding ref: NIHR201483
Sponsor ref: SU/2020/7033
Current treatment and issues
Around 13,500 people in England and Wales are diagnosed with oesophago-gastric (food pipe or stomach) cancer each year. About 5,000 of them (40%) have major surgery.
Patients stay in hospital for around 1-2 weeks after surgery. Even when well enough to continue their recovery at home, patients may still experience surgery-related problems or feel unwell with symptoms such as pain or tiredness.
Aims of the ROSE study
The ROSE study aims to find out if patients recovering at home from surgery for food pipe or stomach cancer benefit from electronic symptom management information (online/web-based).
This is because there is growing evidence that this kind of reporting can improve patients’ well-being – by providing patients with information about how best to manage symptoms. However, this has not yet been studied in patients undergoing surgery for cancer.
Recruitment and trial process
We aim to recruit 206 patients from approximately six NHS hospitals in England. Participants will be randomly placed in one of two groups.
We will ask participants in the ‘electronic information tool’ group to report their symptoms using an electronic (online/web-based) tool, while also receiving their usual care. The tool will provide information about self-care (e.g., self-management of symptoms by the patient) or, if reported symptoms are more serious, provide information to the patient to contact their healthcare team.
Patients in the ‘usual care’ group will not use the electronic information tool to report their symptoms or receive symptom management information.
What we need from people who join the study
All patients will complete questionnaires during the study, including before their surgery, when ready for discharge home and at several intervals up to four weeks thereafter.
We will use the questionnaire answers to see if patients in the ‘electronic information tool’ group have a better recovery from surgery than those in the usual care group. We will also look at whether the electronic information tool is good value for money for the NHS.
